Atara Biotherapeutics, Inc. - stock earnings
ATRA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -69.8 million USD | 2.1 million USD |
| 2023Q2 | -71.1 million USD | 957000 USD |
| 2023Q1 | -74.8 million USD | 1.2 million USD |
| 2022Q4 | -74.6 million USD | 221000 USD |
| 2022Q3 | -84.1 million USD | 4.5 million USD |
| 2022Q2 | 18.5 million USD | 51.6 million USD |
| 2022Q1 | -88.0 million USD | 7.3 million USD |
| 2021Q4 | -93.3 million USD | 7.5 million USD |
| 2021Q3 | -84.7 million USD | 5.4 million USD |
| 2021Q2 | -83.8 million USD | 3.9 million USD |
| 2021Q1 | -78.3 million USD | 3.6 million USD |
| 2020Q4 | -81.3 million USD | ? USD |
| 2020Q3 | -74.3 million USD | ? USD |
| 2020Q2 | -77.5 million USD | ? USD |
| 2020Q1 | -73.5 million USD | ? USD |
| 2019Q4 | -78.5 million USD | ? USD |
| 2019Q3 | -71.9 million USD | ? USD |
| 2019Q2 | -74.3 million USD | ? USD |
| 2019Q1 | -66.3 million USD | ? USD |
| 2018Q4 | -80.0 million USD | ? USD |
| 2018Q3 | -58.4 million USD | ? USD |
| 2018Q2 | -50.9 million USD | ? USD |
| 2018Q1 | -41.4 million USD | ? USD |
| 2017Q4 | -35.3 million USD | ? USD |
| 2017Q3 | -31.1 million USD | ? USD |
| 2017Q2 | -27.4 million USD | ? USD |
| 2017Q1 | -25.7 million USD | ? USD |
| 2016Q4 | -18.2 million USD | ? USD |
| 2016Q3 | -25.4 million USD | ? USD |
| 2016Q2 | -18.9 million USD | ? USD |
| 2016Q1 | -16.6 million USD | ? USD |
| 2015Q4 | -21.2 million USD | ? USD |
| 2015Q3 | -11.9 million USD | ? USD |
| 2015Q2 | -14.9 million USD | ? USD |
| 2015Q1 | -9.2 million USD | ? USD |
| 2014Q4 | -10.5 million USD | ? USD |
| 2014Q3 | -5.9 million USD | ? USD |
| 2014Q2 | -4.5 million USD | ? USD |
| 2014Q1 | -7.0 million USD | ? USD |
| 2013Q4 | -3.6 million USD | ? USD |
| 2013Q3 | -2.5 million USD | ? USD |
| 2013Q2 | -1.4 million USD | ? USD |
| 2013Q1 | -1.3 million USD | ? USD |
ATRA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -290.2 million USD | 4.5 million USD |
| 2022 | -228.3 million USD | 63.6 million USD |
| 2021 | -340.1 million USD | 20.3 million USD |
| 2020 | -306.6 million USD | 3.6 million USD |
| 2019 | -291.0 million USD | ? USD |
| 2018 | -230.7 million USD | ? USD |
| 2017 | -119.5 million USD | ? USD |
| 2016 | -79.0 million USD | ? USD |
| 2015 | -57.2 million USD | ? USD |
| 2014 | -28.0 million USD | ? USD |
| 2013 | -8.8 million USD | ? USD |
ATRA
Price: $0.65
52 week price:
Earnings Per Share: -2.78 USD
P/E Ratio: -0.29
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 783100
Ebitda: -31.4 millionMarket Capitalization: 73.1 million